News Daily News Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients Michael O'Riordan January 17, 2017
News Features Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing Shelley Wood January 04, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular News and Features for 2016 Shelley Wood December 29, 2016
News Opinion Editor's Corner Las Noticias y Blogs Más Populares de TCTMD en 2016 Shelley Wood December 29, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2016 Shelley Wood November 30, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Opinion Editor's Corner TCT 2016 Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones Shelley Wood November 07, 2016
News Daily News FDA Classifies Latest HeartWare VAD Recalls as Class I Michael O'Riordan October 24, 2016
News Daily News St. Jude Medical Warns of Rapid, Unexpected, and Potentially Lethal Battery Depletions With ICDs, CRT-Ds Shelley Wood October 11, 2016
News Daily News Angina Ambigua: La Capacidad de los Médicos a la hora de Identificar Correctamente el Dolor Torácico Varía Enormemente Yael L. Maxwell August 18, 2016
News Daily News Ambiguous Angina: Physicians’ Ability to Properly Identify Chest Pain Varies Widely Yael L. Maxwell August 18, 2016
News Opinion Fellow Talk Hemodynamics Galore: What I Learned at the C3 Summit Tiffany Patterson, MBBS July 27, 2016
News Daily News Abbott Buys St. Jude Medical for $25 Billion, Gaining More Muscle in Cardiovascular Device Arena Michael O'Riordan April 29, 2016